Castration Induced Neuroendocrine Mediated Progression of Prostate Cancer
Abstract
We explored the relationship between androgen withdrawal as an event that initiates a cascade promoting the development of androgen-independent prostate cancer through neuroendocrine progression. We define the early post-castration molecular events and linked androgen-deprivation therapy to the activation of non-receptor tyrosine kinases that promote androgen-independent growth and migration. We developed an animal model to validate this hypothesis that metastasize in SCID mice. We found that deregulation through non-receptor tyrosine kinases was blocked by Src-specific inhibitor AZD0530. We found this inhibited 100% of metastasis in an animal model. The translational benefit of this study was that through a National Cancer Institute sponsored trial, the drug is being tested for hormone refractory prostate cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2008
- Accession Number
- ADA492892
Entities
People
- Christopher P Evans
Organizations
- University of California